Locations
Zürich, Switzerland · Zurich, Switzerland
industry
Biotechnology
Size
11-50 employees
Stage
Other
founded in
2019
Araris Biotech AG is pioneering a novel linker technology for Antibody-Drug Conjugates (ADCs). Our linker platform enables the attachment of any payload to ‘off the shelf’ antibodies without the need of prior antibody engineering.
Something looks off?